Enzon to Present at 29th Annual Cowen and Company Healthcare Conference.BRIDGEWATER Bridgewater, town (1990 pop. 21,249), Plymouth co., E Mass.; inc. 1656. Manufacturing includes shoes and metal products. Its iron foundry industry dates from colonial times. Bridgewater State College and a state prison are there. , N.J. -- Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) announced today that Jeffrey H. Buchalter, Enzon's Chairman and Chief Executive Officer, will present at the 29th Annual Cowen Cowen is the name of: Places:
Boston, town (1991 pop. 26,495), E central England, on the Witham River. Boston's fame as a port dates from the 13th cent., when it was a Hanseatic port trading wool and wine. Having recovered from a decline in the 18th and 19th cent. , MA. Enzon's presentation will take place at 11:05 a.m. ET on Thursday, March 19, 2009. About Enzon Enzon Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to developing, manufacturing and commercializing important medicines for patients with cancer and other life-threatening conditions. The Company has a portfolio of four marketed products, Oncaspar[R], DepoCyt[R], Abelcet[R] and Adagen[R]. Enzon's drug development programs utilize several cutting-edge approaches, including our industry-leading PEGylation technology platform and the Locked Nucleic Acid A locked nucleic acid (LNA), often referred to as inaccessible RNA, is a modified RNA nucleotide. The ribose moiety of an LNA nucleotide is modified with an extra bridge connecting the 2' and 4' carbons. (LNA LNA Low-Noise Amplifier LNA Locked Nucleic Acid (Link Technologies Ltd.) LNA Linolenic Acid LNA Licensed Nursing Assistant LNA Launch Numerical Aperture LNA Ladies National Association LNA Leading National Advertisers, Inc. ) technology. Enzon's PEGylation technology was used to develop two of its products, Oncaspar and Adagen, and has created a royalty revenue stream from licensing partnerships for other products developed using the technology. The Company also engages in contract manufacturing for several pharmaceutical companies to broaden its revenue base. Further information about Enzon and this press release can be found on the Company's web site at www.enzon.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion